The Advertising Law Blog provides commentary and news on developing legal issues in advertising, promotional marketing, Internet, and privacy law. This blog is sponsored by the Advertising, Marketing & Promotions group at Olshan. The practice is geared to servicing the needs of the advertising, promotional marketing, and digital industries with a commitment to providing personal, efficient and effective legal service.
Following the enactment of the European Union’s General Data Protection Regulation (“GDPR”), which went into effect on May 25, 2018, Google has now been fined heavily for violations of the law. On January 21, 2019, the Commission nationale de l’informatique et des libertés (“CNIL”), the French data privacy authority, fined Google €50 million (approximately U.S. $57 million) for violating the GDPR because it did not properly ask its users for consent to use their data to personalize advertising and because the company makes it too hard for users to find out how their personal information is used and how long that information is stored. This is the largest financial penalty for a privacy breach in Europe.
On January 16, 2019, Luxury Daily sponsored its seventh annual Luxury FirstLook conference in New York City, entitled Luxury FirstLook 2019: Digital Acceleration. The expert speakers were extremely informative and included senior executives from numerous companies, including, Facebook, Google, Boston Consulting Group, LVMH Moet Hennessy, Lladro, Town & Country, Artsy, Forrester Research, McLaren Automotive, Valmont, Quintessentially, Flont, Armarium, Perrin Paris, L.K. Bennett, Publicis Groupe’s Team One, Martini Media, Vibes, Leading Real Estate Companies of the World’s Luxury Portfolio, Douglas Elliman, Concierge Auctions, Luxury Institute, Customer Experience Group, PMX Agency, Timeless Distributors, Shanker Inc. and Euromonitor. I was invited to attend as Olshan is legal counsel to Luxury Daily.
New self-regulatory program will actively monitor the direct-selling marketplace
But Don’t Expect the Database Until 2020 at the Earliest
The recently enacted Farm Bill amends the Controlled Substances Act so that hemp and CBD products containing trace amount of THC are not classified as Schedule 1 controlled substances. While many are excited about this amendment, the law does not change FDA’s regulatory requirements for CBD-containing products under its regulatory jurisdiction.